BIO - Bio-Rad Operating income before deduction of amortization

Brandmark of Bio-Rad (BIO)

Bio-Rad Laboratories (BIO) profit dynamics depend on government science funding and demand for digital PCR. Current EBITDA figures visualize these processes, with the value stabilizing at 448.43. Revenue is generated through the supply of blood analysis systems to medical centers. The high reliability and maturity of the product portfolio make the company's solutions an essential foundation for global biomedical research.

Operating profit EBITDA: Bio-Rad Corp (BIO) for 11/23/2025 - 11/10/2026

Summary analytical data breakdowns for Bio-Rad (BIO)

- stock value and consensus price forecast:
Market Chart Bio-Rad Corp|BIO - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Bio-Rad|BIO - Total Company Value
- balance sheet equity data:
Net Assets per Share Bio-Rad|BIO - Book Capitalization|Market Value to Book Value Ratio bio-rad.com|BIO - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Bio-Rad Laboratories|BIO - Long-Term Debt to Equity|Current Liabilities to Capital Bio-Rad Laboratories, Inc.|BIO - Company Total Debt|Debt to Net Assets Bio-Rad|BIO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Bio-Rad|Quick Ratio bio-rad.com
- company profitability and valuation multiples indicators:
BIO - Net Profit|Net Profit Forecast Bio-Rad Laboratories|BIO - Price to Earnings Ratio|Future Price to Earnings Multiple bio-rad.com|BIO - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bio-Rad|BIO - Operating profit EBITDA|Net earnings per share (EPS TTM) Bio-Rad|BIO - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months bio-rad.com|BIO - Earnings per share growth in current year|Expected net earnings per share growth next year Bio-Rad Laboratories
Fundamental company valuation:BIO, Bio-Rad Corp
Signature product of Bio-Rad Laboratories

This metric measures net cash flow from operating activities, deducting direct costs from revenue to determine the actual efficiency of the business. In the case of Bio-Rad Laboratories (BIO), high margins on absolute profit from core operations are driven by a closed equipment ecosystem and patent protection for reagents, making the price action on this chart a key indicator of earnings stability.

Competitors of Bio-Rad Laboratories (BIO)

Operating income before deduction of amortization Agilent Corp (A)|Quest Diagnostics - Operating profit EBITDA|Operating income before deduction of amortization illumina.com ILMN|Exact Sciences Corporation (EXAS) - Profit before payment of interest, taxes and amortization|RVTY - Operating income before deduction of amortization|NNNN (Anbio Tech) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization SHC|Operating profit EBITDA QDEL|Operating income before deduction of amortization opko.com|Profit before payment of interest, taxes and amortization CareDx Inc CDNA|Maravai LifeSciences Holdings (MRVI) - Profit before interest, taxes and amortization|FLGT: Operating profit before deduction of amortization|Operating profit before depreciation charges Standard BioTools Corp (LAB)|Cytek Biosciences, Inc. (CTKB) - Profit before payment of interest, taxes and amortization|orasure.com - Income before deduction of interest, taxes and amortization|XGN (Exagen Inc) - Operating profit EBITDA|Operating profit EBITDA MDxHealth S.A.|Operating profit EBITDA LUCD|prenetics.com - Operating profit before amortization|Insight Molecular Diagnostics Inc - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TRIB|PRPH - Profit before payment of interest, taxes and amortization|AIMD: Profit before payment of interest, taxes and amortization|CODX: Operating profit EBITDA|Heart Test Labs (HSCS) - Operating profit EBITDA|BMRA (Biomerica, Inc.) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization CDIO|Profit before payment of interest, taxes and amortization Onconetix (ONCO)|VRAX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Bluejay BJDX|Income before deduction of interest, taxes and amortization AWH|Accelerate Diagnostics - Operating profit EBITDA|CNTG - Operating profit EBITDA|ENZ (enzo.com) - Operating profit before deduction of amortization|FRES: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Genetic Technologies Ltd|Profit before interest, taxes and amortization 23andMe Inc ME|Profit before payment of interest, taxes and amortization Psychemedics (PMD)